Compare IMNM & GEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | GEO |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.2B |
| IPO Year | 2020 | 1996 |
| Metric | IMNM | GEO |
|---|---|---|
| Price | $24.61 | $18.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $32.80 | ★ $39.67 |
| AVG Volume (30 Days) | 1.2M | ★ 1.6M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.40 | ★ 727.27 |
| EPS | N/A | ★ 1.82 |
| Revenue | $6,941,000.00 | ★ $2,263,420,000.00 |
| Revenue This Year | N/A | $13.74 |
| Revenue Next Year | $1,127.34 | $9.99 |
| P/E Ratio | ★ N/A | $9.95 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $7.15 | $12.51 |
| 52 Week High | $27.65 | $32.09 |
| Indicator | IMNM | GEO |
|---|---|---|
| Relative Strength Index (RSI) | 66.42 | 65.09 |
| Support Level | $23.67 | $16.06 |
| Resistance Level | $25.30 | $18.72 |
| Average True Range (ATR) | 1.13 | 0.74 |
| MACD | 0.36 | 0.03 |
| Stochastic Oscillator | 94.87 | 92.84 |
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.